We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRUGMAKERS WELCOME NEW RISK MANAGEMENT GUIDANCES
DRUGMAKERS WELCOME NEW RISK MANAGEMENT GUIDANCES
May 19, 2004
Acknowledging that risk management is an increasingly important area, drugmakers are welcoming the FDA’s new draft guidances on the issue, noting the documents will help them better understand the agency’s expectations in a field becoming increasingly critical for the pharmaceutical industry.